Literature DB >> 410484

Quantitative bone histology in Paget's disease of bone: influence of sodium etidronate (EHDP) therapy.

M R Khairi, P Meunier, C Edouard, P Courpron, J Bernard, G P DeRosa, C C Johnston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 410484     DOI： 10.1007/bf02064099

Source DB:  PubMed          Journal:  Calcif Tissue Res        ISSN： 0008-0594


× No keyword cloud information.
  3 in total

1.  Physiological senile involution and pathological rarefaction of bone. Quantitative and comparative histological data.

Authors:  P Meunier; P Courpron; C Edouard; J Bernard; J Bringuier; G Vignon
Journal:  Clin Endocrinol Metab       Date:  1973-07

2.  Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).

Authors:  R D Altman; C C Johnston; M R Khairi; H Wellman; A N Serafini; R R Sankey
Journal:  N Engl J Med       Date:  1973-12-27       Impact factor: 91.245

3.  Treatment of Paget disease of bone (osteitis deformans). Results of a one-year study with sodium etidronate.

Authors:  M R Khairi; C C Johnston; R D Altman; H N Wellman; A N Serafini; R R Sankey
Journal:  JAMA       Date:  1974-10-28       Impact factor: 56.272
  3 in total
  3 in total

1.  Osteomalacia in Paget's disease treated with short term, high dose sodium etidronate.

Authors:  C J Gibbs; J E Aaron; M Peacock
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-10

2.  [Diphosphonate for the prevention of an increased ossification process].

Authors:  W Forth
Journal:  Klin Wochenschr       Date:  1986-06-16

3.  Effects of two diphosphonates (EHDP and Cl2MDP) on serum uric acid in pagetic patients.

Authors:  M E Arlot; P J Meunier
Journal:  Calcif Tissue Int       Date:  1981       Impact factor: 4.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.